TERMIUM® is the Government of Canada’s terminology and linguistic data bank. C12N15/ Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming. La présente invention concerne des compositions de microparticules, les microparticules étant constituées d’acides nucléiques et de cations non polymères et.

Author: Vurn Mazukazahn
Country: Czech Republic
Language: English (Spanish)
Genre: Business
Published (Last): 14 June 2006
Pages: 171
PDF File Size: 9.62 Mb
ePub File Size: 20.5 Mb
ISBN: 761-9-20991-972-1
Downloads: 91092
Price: Free* [*Free Regsitration Required]
Uploader: Moogusida

EP EPA2 fr Modulation de la reconnaissance d’exons dans le pre-arnm par interference avec la structure d’arn secondaire. Immobilizing and processing specimens on matrix materials for the identification of nucleic acid sequences.

EP2799548A1 – Acide nucléique antisens – Google Patents

AU Date of ref document: Methods of treating IgE-mediated disorders comprising the administration jucleique high concentration anti-IgE antibody formulations. Polymeres non charges a base de morpholine ayant des liaisons chirales phosphoreuses entre les sous-unites. CN CNB zh Recent advances in the stereocontrolled synthesis of antisense phosphorothioates.

Oligonucleotide comprenant une inosine pour traiter une dystrophie musculaire de duchenne dmd.

Single stranded extended dicer substrate agents and methods for the specific acids of gene expression. Microparticules biodegradables pour administration soutenue de medicaments therapeutiques. Procede servant a produire une preparation complexe contenant des acides nucleiques.

Secuencia oligoribonucleotidica homologa a una region del cdna que codifica para el receptor cd40 humano y oligoribonucleotidos duplex, vectores, composiciones farmaceuticas y usos correspondientes.

Compositions and methods for targeted inactivation of hiv cell surface receptors. Methods for amplifying and detecting multiple polynucleotides on a solid phase support. Multifunctional nanoparticles co-delivering Trp2 nuclleique and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.


Retrograde transport of sirna and therapeutic uses to treat neurologic disorders. Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery. Antisense oligomers and methods for inducing immune tolerance and immunosuppression.

Dosages d’hybridation par la reaction en chaine de la polymerase specifiques a des retrovirus integres.


EP Kind code of ref document: Apparatus and method for simplifying the processes in creating a sealed space on slides to conduct molecular biological reactions therein. Test de malignite test de depistage du cancer par la reaction en chaine de la polymerase. A1 Designated state s: Processes for the preparation of 16beta-alkoxy, 17alpha-hydroxy steroids and steroidal 16beta, 17alpha-diols from 16alpha, 17alpha-epoxy steroids. Amorces de diagnostic et procede de detection des sous-types h5 et h5n1 du virus de la grippe aviaire.

Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists. Kind code of ref document: Composition renfermant de fines particules supportant un principe biologiquement actif ou dont ledit principe actif est maintenu par de telles particules, et procede de preparation.

EPA1 – Acide nucléique antisens – Google Patents

A1 Designated state s: Acide ribonucleique double brin presentant une efficacite accrue dans un organisme. Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents. Procede ameliore de detection et nucleiqque de micro-organismes causes d’infections.


Variable-speed wind power system with improved energy capture via multilevel conversion.

Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination. Kind code of ref document: CA CAA1 fr Efficient, high-throughput production of human proteins in bacteria.

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid.

Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine. In situ forming implants—an attractive formulation principle for parenteral depot formulations. Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof.

In situ hybridization to detect specific nucleic acid sequences in eucaryotic samples. Solution hybridization of nucleic acids with antisense probes having modified backbones. Antisense oligomers and methods for inducing immune tolerance and immunosuppression.

US Ref document number: Kind code of ref document: Request aciee preliminary examination filed prior to expiration of 19th month from priority date pct application filed from Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous nuclfique delivery.

Date of ref document: Nulceique non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? Oligonucleotide compositions and methods for the modulation of the expression of B7 protein.